Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status
1 other identifier
observational
70
1 country
1
Brief Summary
The purpose of the study is to determine associations between fitness status, bacteria in the mouth, and the blood flow to muscle. This study is trying to find out if fitness status impacts the bacteria that are present in the oral microbiome (environment in the mouth) or the ability of the body to send blood to the skeletal muscle. Participants will complete all or some of the following:
- A mouth swab to assess the bacteria in their mouths.
- Produce a saliva sample into a tube.
- Cycle on a bike until you reach maximum effort.
- Undergo blood draws
- Wear a 24-hour non-invasive device that monitors blood pressure.
- Drink 70mL (1/3 of a cup) of concentrated beetroot juice once
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2023
CompletedFirst Posted
Study publicly available on registry
August 24, 2023
CompletedStudy Start
First participant enrolled
August 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
December 24, 2025
December 1, 2025
3.3 years
August 18, 2023
December 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Oral Nitrate Reducing Capacity
Assessment of the oral microbiome's ability to reduce nitrate to nitrite. This will be measured through a swab on the dorsal surface of the tongue, an unstimulated saliva sample, and a rinse of a standard nitrate solution.
Baseline, 4-weeks, 12-weeks, 6-months
Secondary Outcomes (1)
Aerobic Capacity
Baseline, 4-weeks, 12-weeks, 6-months
Other Outcomes (10)
Peripheral and Central Blood Pressures
Baseline, 4-weeks, 12-weeks, 6-months
24-hour ambulatory blood pressure
Baseline, 4-weeks, 12-weeks, 6-months
Flow-Mediated Dilation
Baseline, 4-weeks, 12-weeks, 6-months
- +7 more other outcomes
Study Arms (3)
Heart Failure
Patients diagnosed with Heart Failure (HFrEF and HFpEF). Oral microbiome will be analyzed through tongue swabs, saliva samples, and a saliva rinse. Patients will undergo a maximal exercise test, blood draws, and vascular testing. Patients will have the option to participate in a supplementation assessment with concentrated beetroot juice.
Peripheral Artery Disease
Patients diagnosed with Peripheral Artery Disease (PAD). Oral microbiome will be analyzed through tongue swabs, saliva samples, and a saliva rinse. Patients will undergo a maximal exercise test, blood draws, and vascular testing. Patients will have the option to participate in a supplementation assessment with concentrated beetroot juice.
Healthy Controls
Individuals that are not diagnosed with cardiovascular disease. Oral microbiome will be analyzed through tongue swabs, saliva samples, and a saliva rinse. Patients will undergo a maximal exercise test, blood draws, and vascular testing. Patients will have the option to participate in a supplementation assessment with concentrated beetroot juice.
Eligibility Criteria
The population will include healthy individuals over the age of 18 years of either sex, or individuals with cardiovascular disease (heart failure, peripheral artery disease).
You may qualify if:
- Subjects must be able to communicate meaningfully with the investigator and must be legally competent to provide written informed consent.
- Subjects may be of either sex with age 18 years.
You may not qualify if:
- Oral antibiotic use within previous four weeks
- Oral disease or poor oral health as determined by the Oral Health Questionnaire
- Using an antibacterial mouthwash or a mouthwash containing chlorhexidine and unwilling to discontinue use
- Tobacco smokers
- Pregnant or lactating females
- Hypersensitivity to any ultrasound contrast agent
- Inability to perform exercise
- Unable to communicate effectively in English to the study team.
- Diagnosis of chronic renal failure (GFR \< 60 ml/min/1.73m)
- Subjects taking nitroglycerine (or inorganic nitrates), PDE-5 inhibitors (ex: Cialis, Viagra), and xanthine oxidase inhibitors (ex: Allopurinol).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UVA Student Health and Wellness Building
Charlottesville, Virginia, 22903, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason D Allen, PhD
University of Virginia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Kinesiology
Study Record Dates
First Submitted
August 18, 2023
First Posted
August 24, 2023
Study Start
August 30, 2023
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
December 24, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share